Forecast: Pharmaceutical Industry Trade Balance in Canada

The trade balance of Canada's pharmaceutical industry is projected to continuously worsen from 2024 to 2028, with a deficit increasing from approximately $10.36 billion USD in 2024 to $11.21 billion USD in 2028. Compared to actual data from 2023, this represents a substantial deepening of the trade deficit. The year-on-year increase in the trade deficit highlights a consistent average annual growth in the negative balance, also known as CAGR. These figures indicate a persistent trend of increasing import over export in the pharmaceutical sector in Canada.

Future trends to watch include potential impacts of global supply chain disruptions, changes in regulatory policies, and advancements in domestic pharmaceutical production capacity. Additionally, exchange rate fluctuations and international trade agreements could further influence these projections.

• Watch for impacts from global supply chain changes.
• Monitor regulatory policy adjustments.
• Evaluate domestic production capabilities and advancements.
• Consider exchange rate and trade agreement effects.